These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4149711)

  • 1. Diphenylhydantoin metabolism. A prospective review.
    Glazko AJ
    Drug Metab Dispos; 1973; 1(5):711-4. PubMed ID: 4149711
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
    Butler TC; Dudley KH; Mitchell GN; Johnson D
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenylhydantoin metabolism by rat liver microsomes and some of the effects of drug or chemical pretreatment on diphenylhydantoin metabolism by rat liver microsomal preparations.
    Kutt H; Fouts JR
    J Pharmacol Exp Ther; 1971 Jan; 176(1):11-26. PubMed ID: 5569630
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro.
    Gerber N; Weller WL; Lynn R; Rangno RE; Sweetman BJ; Bush MT
    J Pharmacol Exp Ther; 1971 Sep; 178(3):567-79. PubMed ID: 5571905
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion of phenytoin to reactive metabolites in rat liver microsomes.
    Billings RE; Milton SG
    Adv Exp Med Biol; 1986; 197():931-9. PubMed ID: 3020938
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions between folate metabolism, phenytoin metabolism, and liver microsomal cytochrome P450.
    Billings RE
    Drug Nutr Interact; 1984; 3(1):21-32. PubMed ID: 6510238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat.
    Wesseling H; Thurkow I; Mulder G
    Biochem Pharmacol; 1973 Dec; 22(23):3033-40. PubMed ID: 4761563
    [No Abstract]   [Full Text] [Related]  

  • 9. The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats.
    Tsuru M; Erickson RR; Holtzman JL
    J Pharmacol Exp Ther; 1982 Sep; 222(3):658-61. PubMed ID: 7108769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine metabolism. I. Evidence for separate enzymes in the glucuronidation of morphine and p-nitrophenol by rat hepatic microsomes.
    Sanchez E; Tephly TR
    Drug Metab Dispos; 1974; 2(3):247-53. PubMed ID: 4152964
    [No Abstract]   [Full Text] [Related]  

  • 11. A 3-O-methylated catechol metabolite of diphenylhydantoin (Dilantin) in rat urine.
    Chang T; Okerholm RA; Glazko AJ
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):13-23. PubMed ID: 4671868
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
    Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH
    Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a catechol glucuronide metabolite of 5,5-diphenylhydantoin (DPH) in rat bile by gas chromatography (GC) and mass spectrometry (MS).
    Gerber N; Seibert RA; Thompson RM
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):499-511. PubMed ID: 4750099
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative separation of diphenylhydantoin and its para-hydroxylated metabolites by high-performance liquid chromatography.
    Albert KS; Hallmark MR; Carroll ME; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):845-54. PubMed ID: 4760892
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro hydroxylation of diphenylhydantoin and its inhibition by other commonly used anticonvulsant drugs.
    Patsalos PN; Lascelles PT
    Biochem Pharmacol; 1977 Oct; 26(20):1929-33. PubMed ID: 911347
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolated rat hepatocytes as a model to study drug metabolism: dose-dependent metabolism of diphenylhydantoin.
    Inaba T; Umeda T; Mahon WA; Ho J; Jeejeebhoy KN
    Life Sci; 1975 Apr; 16(8):1227-32. PubMed ID: 1134191
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism of folate-2-C 14 in the mammal. Intracellular and organ distribution and urinary elimination.
    Sankar DV; Rozsa PW
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):93-113. PubMed ID: 4671939
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin.
    Billings RE
    J Pharmacol Exp Ther; 1983 Jun; 225(3):630-6. PubMed ID: 6864524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygenated norethindrone derivatives from incubation with beagle liver. Structure, synthesis, and biological activity.
    Cook CE; Dickey MC; Christensen HD
    Drug Metab Dispos; 1974; 2(1):58-64. PubMed ID: 4150135
    [No Abstract]   [Full Text] [Related]  

  • 20. Folic acid and the half-life of diphenylhydantoin in man.
    Andreasen PB; Hansen JM; Skovsted L; Siersbaek-Nielsen K
    Acta Neurol Scand; 1971; 47(1):117-9. PubMed ID: 5576217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.